AHSCT RUSSIA
General Information
Stages of Treatment
Advantages of Program
Eligibility Criteria
Application for Treatment
Preparation for Treatment
Pre-Transplant Examination
Admission to the Hospital
Follow-Up After HSCT
Webinar with Dr.Fedorenko
International Conference
About us
Language Menu ⇨
Site Map
© All Right Reserved. AHSCT RUSSIA, Moscow 2020.
⇦ Main Menu
Arabic
English
Deutsch
Nederlands
Français
Italiano
Norsk
Español
Serbian
Application
Admission
SiteMap
Language Menu ⇨
Approach
Advantages
Eligibility Criteria
Preparation
Examination
Treatment
Follow Up
Webinar
Conference
About us
Application
Admission
SiteMap
Online Consultation
About HSCT treatment for Autoimmune Diseases
with
MD, PhD, Dr. Denis Fedorenko
Join (Zoom App)
Check what time it will be in your location - (24TimeZones.com)
Washington, Ottawa
USA, Canada
17.05.2025 - 13:00
United Kingdom, Ireland
17.05.2025 - 18:00
Austria, Belgium, Croatia, Czechia, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland.
Europe
17.05.2025 - 19:00
Bulgaria, Romania
17.05.2025 - 20:00
Russia, Saudi Arabia, Turkey
17.05.2025 - 21:00
Canberra
Australia
17.05.2025 - 05:00
New Zealand
18.05.2025 - 07:00
LAST Webinar record
Sunday 21, December
(2025)
A list of underlying medical conditions for HSCT treatment of autoimmune diseases
Webinar records with PhD, MD, Dr. Denis Fedorenko
Intermediate-Intensity Chemotherapy (IDCT) + AHSCT for patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Indications and Efficacy of Disease-Modifying Therapies and Supportive Care of Multiple Sclerosis
Research Article: Acta Scientific Neurology (ASNE) Volume 8 Issue 11 November 2025
Comparison of HSCT treatment protocols available to foreign citizens